Stay updated with breaking news from Mci. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The US Food and Drug Administration has approved lecanemab for patients with Alzheimer's disease, even though trial results showed modest cognitive benefits and cases of amyloid-related imaging abnormalities.
IOWA CITY, Iowa, Jan. 03, 2023 (GLOBE NEWSWIRE) -- MCI Capital, LC (“MCI”), a wholly-owned subsidiary of MCI, LC, announced today that it is...
NEW YORK, Dec. 30, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating...
Higher handgrip strength and better mobility correlate with larger brain volumes in cognitively impaired adults with biomarker evidence of dementia.
It's not home for the holidays for many at MCI this week